Skip to content
drillr.ai
Sign up

600285.SH

Henan Lingrui Pharmaceutical Co., Ltd.

SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

CNY 19.97
−1.63%
Ask drillr

  • Oct 13, 2026, 07:57 UTC

    Henan Lingrui Group Co., Ltd. released its pledge on 5.2 million shares of Lingrui Pharmaceutical on October 12, 2026, representing 4.27% of its holdings and 0.92% of the company’s total shares.

    Source:

  • Sep 29, 2026, 07:33 UTC

    Lingrui Group, major shareholder of Lingrui Pharmaceutical, released a pledge on 9.1 million shares and re-pledged 5.15 million shares for working capital financing.

    Source:

  • Aug 20, 2026, 22:22 UTC

    As of August 20, 2026, more than 30 A-share listed companies disclosed securities firms among their top ten circulating shareholders in their 2026 semi-annual reports, with some firms increasing stakes and others newly appearing.

    Source:

  • Aug 11, 2026, 09:20 UTC

    Lingrui Pharmaceutical disclosed its semi-annual report on August 11, reporting revenue of 2.148 billion yuan, up 2.32% year-on-year, and net profit attributable to shareholders of 495 million yuan, up 4.36% year-on-year.

    Source: